Introduction
Endometriosis is defined as the development of ectopic endometriumlike tissue outside of the uterine cavity (Sampson, 1927) . In terms of clinical appearance, there are three endometriosis phenotypes: (Tosti et al., 2015) superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE).
Adenomyosis is a neglected enigmatic (Benagiano et al., 2012) , benign gynecologic disease characterized by infiltration of endometrial tissues (endometrial glands and stroma) into the myometrium that causes myometrial inflammation and hypertrophy (Bird et al., 1972; Siegler and Camilien, 1994) . The disease leads to pain (Parker et al., 2006; Guo et al., 2013) , infertility (Vercellini et al., 2014) and uterine bleeding (Naftalin et al., 2014) with a consequent negative impact on patient quality of life (Ekin et al., 2013; Iacovides et al., 2015) . Adenomyosis is a heterogeneous disease that may present in different configuration in the myometrium: diffuse, focal and rare cases of cystic adenomyoma (Bergeron et al., 2006; Gordts et al., 2008; Kishi et al., 2012) . Adenomyosis must be considered as diffuse when numerous foci of endometrial glands and stroma are dispersed diffusely within the myometrium and focal when circumscribed nodular aggregates are observed (Van den Bosch et al., 2015) . Cystic adenomyoma is a rare variation of focal adenomyosis with additional compensatory hypertrophy of the surrounding myometrium (Van den Bosch et al., 2015) . There is a tight relationship between endometriosis and adenomyosis (Kunz et al., 2005; Leyendecker et al., 2015; Yasui et al., 2015) . In some studies (Kunz et al., 2005; Larsen et al., 2011) , this relationship was assessed as a function of the severity of the endometriosis according to the revised American Society for Reproductive Medicine classification (rAFS) (rAFS, 1997) .
The aim of our study was to investigate the relationship between endometriosis phenotypes (SUP, OMA and DIE) and magnetic resonance imaging (MRI) appearance of adenomyosis.
Materials and Methods

Ethical approval
The local ethics committee (CCPPRB: Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale) of our institution approved the study protocol and all of the included patients provided a signed informed consent form.
Patients
We performed a prospective observational study evaluating symptomatic women younger than 42 years of age who were undergoing surgery for benign gynecological pathologies. Indications for surgery (possibly more than one per patient) included: (i) infertility: defined as at least 12 months of unprotected intercourse not resulting in pregnancy (Marcoux et al., 1997) ; (ii) pelvic pain: defined as the presence, for at least 6 months, of dysmenorrhea and/or intermenstrual pelvic pain and/or dyspareunia of moderate to severe intensity (Fedele et al., 2005) ; (iii) a pelvic mass (e.g. uterine myomas, benign ovarian cysts, etc.); (iv) miscellaneous: e.g. uterine bleeding, request for tubal ligation, infection etc. Excluded from this population were the following: (i) patients who had undergone surgery for cancer; (ii) pregnant patients (i.e. ectopic pregnancies); (iii) endometriotic patients for whom surgical exeresis was considered as being incomplete by the surgeon (Lafay Pillet et al., 2014; Sibiude et al., 2014) . All women underwent preoperative MRI.
For the purpose of this study, patients retained for analysis were divided into two groups: Group A (the endometriosis group) included women with histologically proven endometriosis, and Group B (the endometriosis free group) included patients without any visual endometriotic lesions as determined during the surgical procedure. Patients who were visually diagnosed as having endometriosis but lacking histological confirmation were excluded from the study (Chapron et al., 2010) . Histologically proven endometriotic lesions were classified into three phenotypes: SUP, OMA and DIE, as previously described (Chapron et al., 2010a (Chapron et al., ,b, 2011 . Since the three types of endometriotic lesions (SUP, OMA and DIE), can be associated, patients were classified according to their most severe lesion. By definition, endometriosis phenotypes were ranked from least to most severe as follows; SUP, OMA and DIE (Chapron et al., 2011) .
For each patient, data were recorded during face-to-face interviews conducted by the surgeon in the month preceding the surgery, using a structured previously published questionnaire (Chapron et al., 2010a,b) . For each painful symptom, the intensity was assessed using a 10-cm visual analog scale (VAS) (Peveler et al., 1996) . When present during surgery, the extent of the endometriosis (e.g. stages and mean scores: total, implants and adhesions) were assessed according to the revised American Fertility Society (rAFS) classification of endometriosis (rAFS, 1997).
MRI examination
All pelvic MRI examinations were performed on a 1.5 T MRI machine (Sonata, Siemens; Erlangen, Germany). The patients were placed in a phased-array coil in a supine position. All sequences were performed with saturation bands placed anteriorly and posteriorly to eliminate artifacts from the high subcutaneous fat signal. The patients fasted for 3 h and received a bowel preparation (Microlax ® : sorbitol, citrate and sodium lauryl sulfoacetate) 12 h prior to the MRI. No antiperistaltic drugs were administered. The acquisition protocols were acquired with 5 mm thick-section and a 1 mm gap, a rectangular field of view of 270 × 270 mm and a matrix of 320 × 320 pixels. The protocol always included sagittal and transverse fast spin-echo T2-weighted MR imaging, transverse gradient-echo T1-weighted MR imaging, with and without fat suppression. The fast spin-echo T2-weighted sequence was performed with the following imaging parameters: repetition time ms/echo time ms, 4000/120 (effective); echo train length, 35; and the number of signals acquired was two. T1-weighted spin-echo sequences were performed with 322/4.8 and one signal was acquired. MRI results were interpreted by a single radiologist (A-.E.M.), with expertise in gynecological MRI (10 years of referral practice and a mean of 1000 scans/year).
Three criteria were assessed on T2-weighted acquisitions (Bazot et al., 2001) : (i) Maximal Junctional Zone (JZ max ) thickness corresponding to a low signal intensity band of myometrium lining the endometrium (Novellas et al., 2011) ; (ii) JZ max to myometrial thickness ratio (ratio max ) using the maximal thickness of the JZ and the corresponding thickness of the myometrium obtained at the same level of measurement; (iii) the presence of high-intensity spots within the myometrium. In this study, diffuse adenomyosis was defined by the association of the two following criteria: (i) JZ max of at least 12 mm (Reinhold et al., 1996; Bazot et al., 2001; Kunz et al., 2005) and (ii) ratio max > 40% (Bazot et al., 2001) .
Concerning focal adenomyosis, the radiologist was asked to thoroughly define the foci location within the myometrium on axial and sagittal T2 planes. The size of the lesion (length × width) was provided systematically. Three subtypes of focal adenomyosis according to the foci location in the outer, middle and inner myometrium were previously described (Gordts et al., 2008; Kishi et al., 2012) . By definition, in this study, we consider as focal adenomysosis only adenomyotic foci located in the outer shell of the uterus, separated from the JZ (Arnold et al., 1995) , which was kept intact and with preserved healthy muscular structures between the adenomyosis and the JZ (Kishi et al., 2012) . In this study, focal adenomyosis correspond to the sub-type II (extrinsic) according to the Kishi' Classification (Kishi et al., 2012) and must be considered as focal adenomyosis located in the outer myometrium (FAOM) (Fig. 1) .
The radiologist (A-.E.M.) was informed that endometriosis and/or adenomyosis were suspected, but was blinded to the results of the clinical findings and previous imaging examinations (Piketty et al., 2009 ).
Statistical analyses
Data were presented as the mean ± SD or as the number (percent) for continuous and categorical variables, respectively. We compared the prevalence of adenomyosis in the Group A (the endometriosis group) and in the Group B (the endometriosis free group), taking into account the endometriosis phenotypes (SUP, OMA or DIE). Between-group comparisons were performed using the Pearson's Chi 2 or Fisher's exact tests for categorical variables and the Student's t-test for numerical variables. A P-value of 0.05 was considered as statistically significant. The statistical analyses were performed using SPSS software version 15.0 (SPSS Inc., Chicago, IL, USA).
Results
During the study period, 292 patients were enrolled. Group A (the endometriosis group) included 237 women (81.2%) with histologically proven endometriosis upon surgery, and Group B (the endometriosis free group) included 55 patients (18.8%) without any visual endometriotic lesions at the time of surgery. Indications for surgery in the endometriosis free group, which were sometimes more than one for the same patient, were the following: benign ovarian cyst (6 cases; 10.9%), uterine myomas (26 cases; 18.2%), pelvic pain (16 cases; 29.1%), tubal infertility (4 cases; 7.3%) and others (3 cases; 5.4%). The patient distribution according to their most severe endometriotic lesion was as follows: SUP (40 patients; 16.9%), OMA (31 patients, 13.1%) and DIE (166 patients; 70.0%). Among the DIE patients, 66 (39.8%) were also diagnosed with an associated OMA for a total 97 endometriotic patients (40.9%) with OMA (right 21, left 46 and bilateral 30). For DIE patients (n = 166), the distribution according to the main DIE location was as follows: uterosacral ligament(s) (USL) (16 patients; 9.6%), vagina (10 patients; 6.0%), bladder (12 patients; 7.3%), intestine (112 patients; 67.5%) and ureter (16 patients; 9.6%). Taking into account the bilaterality of certain DIE lesions (USL, ureter) and the multifocality of intestinal DIE, 546 histologically proven DIE lesions were observed after complete surgical exeresis. Thus, the anatomical distribution of the DIE lesions was as follows: USL (146 DIE lesions), vagina (88 DIE lesions), bladder (31 DIE lesions), intestine (261 DIE lesions) and ureter (20 DIE lesions). The patients' baseline characteristics are detailed in Table I . The MRI adenomyosis appearance distribution was detailed in the Table II. In the total sample population (n = 292), adenomyosis was observed in 59.9% (n = 175). Diffuse and FAOM can occur in the same patient (48 cases) ( Fig. 1 and Table II ). The mean size of the FAOM nodule was 15.9 ± 5.2 mm (range 5-34 mm). Diffuse adenomyosis was observed in one-third of the patients whether they were endometriotic patients or endometriosis free women (34.2% (81 cases) versus 36.4% (20 cases) respectively; P = 0.764). For endometriotic patients (n = 237), diffuse adenomyosis (isolated and associated to FAOM) failed to reach significant correlation with the endometriosis phenotypes (Table II) . Diffuse adenomyosis was observed more frequently in women with DIE or OMA than in women with SUP (37.0% (73/197) and 20.0% (8/40), respectively, P = 0.032). These relationships between diffuse adenomyosis and endometriosis were observed irrespective of the MRI criteria for severity that were used to define diffuse adenomyosis (JZ max ≥ 12 or ≥ 15 mm; JZ max and/or ratio max ) (Supplementary data, Table S1 ). FAOM was observed significantly more frequently in the endometriosis group than in the endometriosis free group (119 cases (50.2%) versus 5.4% (3 cases); P < 0.001). For endometriotic patients (n = 237), FAOM correlated with the endometriosis phenotypes (P < 0.001) (Table II) .
Discussion
This prospective study demonstrates that, in a population of symptomatic women younger than 42 years of age, FAOM was more frequently observed in women with endometriosis than in endometriosis free women taken as controls, and was significantly associated with a DIE endometriosis phenotype. Diffuse adenomyosis is observed in one-third of the patients whether they were endometriotic patients or not. Diffuse adenomyosis failed to reach significant correlation with the endometriosis phenotypes (SUP, OMA or DIE).
The strength of this study is based on the following aspects: (i) the selection of the study population was based on strict surgical and histological criteria. Women allocated to endometriosis free group were surgically explored and presented no visual endometriosis lesions. Women in the endometriosis group had histologically proven . MRI sagittal T2-weighted image reveals a focal hypointense focused area in the posterior wall of the myometrium (white arrows) exhibiting focal adenomyosis located in the outer myometrium without any diffuse adenomyosis (thin Junctional Zona (white line), and no hyperintense T2 foci). The intermediate intensity reaching at least up to the fundal part of the uterine cavity, corresponds to a partial volume on the endometrium. The lesion is contiguous to a deep infiltrating lesion (white arrowhead). (e and f) MRI with isolated posterior FAOM (sub-type II Kishi) (Kishi et al., 2012) (a 34-year-old woman). MRI Axial T2-weighted (e) and sagittal T2-weighted (f) image demonstrates focal hypointense focused area, located in the posterior wall of the myometrium (white star). The lesion is contiguous to a deep infiltrating bowel lesion (white arrow). (g) MRI with associated diffuse and FAOM (sub-type II Kishi) (Kishi et al., 2012) (a 32-year-old woman). MRI sagittal T2-weighted image through the mid portion of the uterus reveals focalized posterior adenomyosis (FAOM) (white arrows) with hyperintense focal signals. Diffuse adenomyosis added as a thickening of the JZ (black area highlighted by the white line) anterior and posterior to the hyperintense normal appearing endometrium (white star). FOAM is contiguous to a deep infiltrating lesion (white arrowhead). JZ, junctional zone; MRI, magnetic resonance imaging; FAOM, focal adenomyosis located in the outer myometrium. endometriotic lesions; (ii) the results were analyzed according to the three endometriosis phenotypes, with a large number of DIE patients; (iii) the results were analyzed according to whether the adenomyosis was diffuse and/or focal; (iv) Relationships between diffuse adenomyosis and endometriosis were similar, irrespective of the MRI criteria used to define diffuse adenomyosis (JZ max ≥ 12 or ≥ 15 mm; JZ max and/or ratio max ); (v) clinical data were recorded prospectively by the surgeon during face-to-face interviews in the month prior to the surgery using a structured questionnaire; (vi) during the preoperative imaging work-up, the radiologist was informed that endometriosis and/or adenomyosis were suspected, but they were blinded to the results of the clinical findings and previous imaging examinations.
Our study also has some limitations: (i) this study was performed with a patient population that required surgical intervention for symptomatic benign gynecological conditions. One can hence speculate that the results may have been affected by the nature of the patients included in the study design. Including symptomatic women, with dysmenorrhea in 39/ 55 (70.9%) endometriosis free women, could select women with adenomyosis and could explain the high proportion of women with adenomyosis observed in the endometriosis free group. Whether this selection could have introduced a bias in the relationship between endometriosis and adenomyosis remains unknown. (ii) The number of patients was much smaller for the endometriosis free group (55 versus Deep dyspareunia 4.9 ± 3.3 3.9 ± 3.7 0.069
Non-cyclic chronic pelvic pain 3.2 ± 3.0 2.2 ± 3.2 0.032
Gastrointestinal symptoms 5.0 ± 3.5 2.2 ± 3.1 <0.001
Lower urinary tract symptoms 1.7 ± 2.9 0.2 ± 1.3 <0.001
n.a., not applicable; OCs, oral contraceptives; OMA, ovarian endometrioma; VAS, visual analog scale; ASRM, American Society for Reproductive Medicine. *Score according to the American Society for Reproductive Medicine classification (rAFS, 1997).
is not possible in daily practice to provide a preoperative MRI to all of the patients presenting with suspected endometriosis, it is even more difficult to provide it to patients before they undergo intervention for another benign gynecologic indication (e.g. tubal infertility; non endometriotic benign ovarian cyst, etc.); (iii) Imaging has led to numerous types of adenomyosis being reported, thus leading to several adenomyosis classifications (Gordts et al., 2008; Kishi et al., 2012; Pistofidis et al., 2014) . In our study, the results were analyzed based on whether the adenomyosis was diffuse and/or focal, using the above reported strict MRI criteria. Furthers studies are necessary to demonstrate if our results are also observed with others adenomyosis classifications; (iv) The difference between the ZJ maximum and minimum thickness (JZ max − JZ min ) seems to also be an accurate MRI criterion for the diagnosis of adenomyosis (Dueholm and Lundorf, 2007) . Further work will be required to determine whether our results also hold up when JZ max − JZ min are taken as the MRI criterion for adenomyosis diagnosis. In the future, the development of more accurate imaging criteria would optimize the diagnostic process allowing a more precocious diagnosis of adenomyosis. Our studies show that diffuse adenomyosis is a common pathology, and that it can be encountered in young patients, including those who . do not have associated endometriosis. The mean age of women with isolated diffuse adenomyosis in this study was 33.2 ± 5.3 years (range 22-41 years). We found that diffuse adenomyosis occurred in onethird of the patients (34.6%, 101/292), regardless of whether they were endometriosis free or not. Diffuse adenomyosis should no longer be considered to be a disease of older multiparous patients with an associated endometriosis (Naftalin et al., 2012) as it can also be encountered in younger women (Kunz et al., 2000 (Kunz et al., , 2005 Suginami, 2001; Leyendecker et al., 2006; Zacharia and O'Neill, 2006; Kissler et al., 2007) , including adolescents (Brosens et al., 2015; Mansouri et al., 2015) . It is paramount to bear this observation in mind in daily practice in the sense that adenomyosis is a factor in infertility, it causes pelvic pain, and it contributes to menorrhagia.
According to our results, diffuse and focal adenomyosis differ in terms of their relationship with endometriosis phenotypes. FAOM is significantly associated with endometriosis and specifically with the DIE phenotype. While the pathogenesis of endometriosis has remained elusive, retrograde menstruation remains the most commonly accepted theory (Sampson, 1927) . The Sampson hypothesis provides an explanation for the anatomical distribution of endometriotic lesions (Chapron et al., 2006) . Endometriotic lesions are more commonly seen in the posterior pelvic compartment and on the left pelvic sidewall (Vercellini et al., 2004; Bricou et al., 2008) . Regurgitant menstrual flow in the abdominal pelvic cavity gives rise to an inflammation (McKinnon et al., 2015) responsible for an adherential process that leads to a degree of obliteration of the pouch of Douglas (Vercellini et al., 2000) . While ectopic endometriotic cells have the potential to penetrate the posterior vaginal fornix, the rectovaginal septum and the rectosigmoid, there is no scientific evidence that allows for exclusion of the hypothesis that these same cells can also infiltrate the posterior uterine wall to form a posterior focal adenomyotic nodule opposite to the posterior intestinal DIE lesion (Khong et al., 2011) (Fig. 2b ). For these same reasons, Fedele et al. (1997) applied this physiopathological argument at the level of the vesico-uterine pouch to explain the observation of a bladder DIE lesion in front of an anterior uterine wall adenomyotic nodule. Our findings indicate that diffuse adenomyosis is only associated to some extent with endometriosis phenotypes. Recent evidence suggests that an epithelial-mesenchymal transition (EMT) is involved in the pathogenesis of adenomyosis, thereby resulting in increased invasiveness of endometrial cells (Chen et al., 2010) by a range of pathogenic mechanisms (Leyendecker et al., 2009; Oh et al., 2013; Khan et al., 2015; Qi et al., 2015; Guo et al., 2016; Liu et al., 2016; Shen et al., 2016) (Fig. 2a) .
In conclusion, based on a population of young women who underwent surgery for benign gynecological disease, our study demonstrates that adenomyosis is a common occurrence. FAOM is more commonly seen in endometriotic patients, and it is significantly correlated with the DIE endometriosis phenotype. Diffuse adenomyosis is encountered in one-third of the population (endometriotic or not) and failed to reach significant correlation with the endometriosis phenotype. These results raise the question of whether diffuse and FAOM are two different entities.
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Supplementary data are available at Human Reproduction online.
